Short-term steroids for steroid-sensitive nephrotic syndrome
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a shorter course of steroids works well for adults with steroid-sensitive nephrotic syndrome. If you have this condition and your protein levels are very high, this study may help find a treatment that is just as effective but with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high protein in your urine (protein to creatinine ratio of at least 3000 mg/g).
- Your blood albumin level is less than 30 g/L.
- You are 16 years or older.
- You have not had prior steroid or immune-suppressing treatment for any kidney disease, except for the first 28 days of prednisolone given as standard care.
- You have no other known cause for your kidney problems, such as a systemic disease or exposure to certain drugs.
- Your nephrotic syndrome is steroid-sensitive, meaning it goes away within 4 weeks of taking prednisone or prednisolone at the usual dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether rituximab works as well as mycophenolate in children whose nephrotic syndrome (kidney condition) comes back when steroid medicines are reduced. It aims to find the safest and most effective option during a relapse.
This study tests an injection (SG301) that targets a protein called CD38 to help children whose nephrotic syndrome keeps coming back or depends on steroids. The goal is to see if the treatment can reduce relapses and the need for steroids.
This trial tests rituximab, a medicine that affects the immune system, in children who have their first episode of steroid-sensitive nephrotic syndrome and are in remission at enrollment. It aims to see whether rituximab helps prevent relapse and improves kidney outcomes with fewer steroid needs.
This trial tests if a hormone called ACTH can help children with nephrotic syndrome who have frequent relapses or need steroids to stay in remission. It aims to find a treatment that may reduce the need for steroids and prevent relapses.
This study is looking for children newly diagnosed with idiopathic nephrotic syndrome (a kidney condition that causes swelling and protein in the urine) who have not yet been treated. Researchers will study their blood and genes to find better ways to predict how the disease will progress and which treatments might work best.
This study aims to improve how doctors diagnose nephrotic syndrome by using a personalized workflow. If you have nephrotic syndrome and are under 40 years old, this trial might help find the best treatment for your specific type.
Hear when a new Idiopathic Nephrotic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.